Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study

BACKGROUND: Papillary thyroid carcinoma (PTC) usually has an indolent clinical course, yet a subset of patients might show an aggressive course. Thus, better stratification of at-risk patients is mandatory for proper management. Solute carrier family 34 member 2 (SLC34A2) is an independent prognosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hakim, Sarah Adel, Abd El Atti, Rasha Mohamed, Faheim, Reham Mohamed, Abou Gabal, Hoda Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298178/
https://www.ncbi.nlm.nih.gov/pubmed/34336552
http://dx.doi.org/10.1155/2021/3198555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298178/
https://www.ncbi.nlm.nih.gov/pubmed/34336552
http://dx.doi.org/10.1155/2021/3198555

Ejemplares similares